Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
294
-
Total 13F shares, excl. options
-
21M
-
Shares change
-
-80.9K
-
Total reported value, excl. options
-
$1.84B
-
Value change
-
-$6.56M
-
Number of buys
-
145
-
Number of sells
-
-127
-
Price
-
$87.51
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q3 2025
320 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q3 2025.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 294 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21M shares
of 22.7M outstanding shares and own 92.5% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3.11M shares), VANGUARD GROUP INC (1.6M shares), Conestoga Capital Advisors, LLC (1.57M shares), Copeland Capital Management, LLC (940K shares), GENEVA CAPITAL MANAGEMENT LLC (912K shares), FIRST TRUST ADVISORS LP (829K shares), STATE STREET CORP (801K shares), CONGRESS ASSET MANAGEMENT CO (692K shares), PRICE T ROWE ASSOCIATES INC /MD/ (528K shares), and GEODE CAPITAL MANAGEMENT, LLC (527K shares).
This table shows the top 294 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.